Research Archive — Page 27 of 139
-
November 19, 2024
Eleven Vanderbilt scientists among world’s ‘highly cited’ researchers
The list recognizes both the scientific achievements of individual scientists and “their profound impact on tackling broader societal challenges.” -
November 15, 2024
New radiation therapy approach for treating lung cancers
VUMC researchers tested a treatment combining immunotherapy and online adaptive radiotherapy, which is tailored to real-time tumor changes during the treatment plan. -
November 15, 2024
Zinc deficiency promotes Acinetobacter lung infection: Study
The study findings point to the potential of interleukin-13 antibodies — approved for use in humans — as a treatment to protect against bacterial pneumonia in patients with zinc deficiency. -
November 14, 2024
VUMC receives $3.3 million ARPA-H award to develop at-home therapy for preterm labor
This project will be the first to apply drug conjugates in the field of obstetrics. -
November 14, 2024
Studies to explore molecular drivers of pulmonary diseases
Three grants, totaling over $22 million, were awarded by the National Institutes of Health’s National Heart, Lung, and Blood Institute and will be led by a team of VUMC investigators. -
November 13, 2024
New Video: Only half of young cancer patients report discussing fertility preservation
Young patients with thyroid, lung, ovarian and colorectal cancers reported the lowest prevalence of a fertility preservation discussion. -
November 12, 2024
GLP-1 medicines are focus of Discovery Lecture on Nov. 21
Daniel Drucker, MD, a pioneering scientist whose research contributed to the development of the blockbuster GLP-1 medicines used to treat diabetes and obesity, was listed by TIME magazine as one of the 100 Most Influential People of 2024.